Jordan vs Middle East, North Africa, Afghanistan & Pakistan: Treatment for hypertension, male

Jordan
51.5%
in 2019
Middle East, North Africa, Afghanistan & Pakistan
32.3%
in 2019
Jordan rank
26th
Middle East, North Africa, Afghanistan & Pakistan rank
23rd

Treatment for hypertension, male over time

  • Jordan
  • Middle East, North Africa, Afghanistan & Pakistan
20304050199020042019

How they compare

Jordan currently reports 51.5% against 32.3% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 19.2%.

That makes Jordan's figure about 1.6 times Middle East, North Africa, Afghanistan & Pakistan's.

Across all 30 years both countries report, Jordan has been ahead every year.

Jordan ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 23rd of 192 countries.

Jordan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Jordan Middle East, North Africa, Afghanistan & Pakistan Difference Ahead
1990s 26.5% 17.5% 9.0% Jordan
2000s 37.4% 24.3% 13.1% Jordan
2010s 48.6% 30.8% 17.8% Jordan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, male, Jordan or Middle East, North Africa, Afghanistan & Pakistan?
Jordan, at 51.5% against 32.3% in Middle East, North Africa, Afghanistan & Pakistan as of 2019.
What is the difference in treatment for hypertension, male between Jordan and Middle East, North Africa, Afghanistan & Pakistan?
19.2%, with Jordan ahead.
How many years of comparable data are there for Jordan and Middle East, North Africa, Afghanistan & Pakistan?
30 years are reported by both, from 1990 to 2019.
How do Jordan and Middle East, North Africa, Afghanistan & Pakistan rank globally for treatment for hypertension, male?
Jordan ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 23rd of 192 countries.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Jordan vs Middle East, North Africa, Afghanistan & Pakistan: Treatment for hypertension, male. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/jordan/middle-east-north-africa-afghanistan-and-pakistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/jordan/middle-east-north-africa-afghanistan-and-pakistan/">Jordan vs Middle East, North Africa, Afghanistan & Pakistan: Treatment for hypertension, male</a> — Statizoid

About this data

Indicator
Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Unit
% of male adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.